Select Publications
Conference Presentations
2022, 'The role of point-of-care hepatitis C RNA testing at prison intake for reducing barriers to the hepatitis C care cascade', presented at Australasian Viral Hepatitis Conference, Brisbane, 29 May 2022 - 31 May 2022
,2021, 'Perceptions and concerns of hepatitis c reinfection in the prison setting', presented at Justice Health Conference, Public Health Association Australia, Virtual (Australia), 03 November 2021 - 04 November 2021
,2021, 'Correctional Officers and Health Staff Perspectives Of Hepatitis C Treatment As Prevention Scale Up Within The Prison Setting', presented at International Conference on Health and Hepatitis in Substance Users (INHSU), Virtual (International), 13 October 2021 - 15 October 2021
,2021, 'Scaling Up Hepatitis C Treatment within the Prison Setting: The Role of Social Capital', presented at Academic and Health Policy Conference on Correctional Health (ACCJH), Virtual (USA), 08 April 2021 - 10 April 2021
,2021, 'Optimised approach for high throughput hepatitis C virus amplification for transmission cluster identification in Australian prisons', presented at 16th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Bowral, Australia
,2020, 'Resolving within-host, full length, dengue virus variants without haplotype reconstruction using Oxford Nanopore Technology', presented at ECCMID 2020, Paris, France
,2019, 'A single nested PCR method for full length dengue virus genome amplification', presented at 7th European Congress of Virology, Rotterdam, The Netherlands
,2019, 'Using networks to study epistatic interactions of HCV', presented at 14th Scientific Workship of the Australian Center for HIV and Hepatitis Virology Research, Canungra, Australia
,2019, 'Whole genome long read sequencing of Hepatitis C virus and its applications', presented at 14th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Canungra, Australia
,2018, 'Challenges in characterizing hepatitis C virus founder variants with deep sequencing', presented at 13th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research
,2018, 'Genetic variability of Hepatitis C quasi-species in early infection', presented at Global Hepatitis Summit, Toronto, Canada
,2018, 'Host IFNλ3 genotype and viral genotype are key determinants of within-host HCV genomic variation in early infection', presented at 13th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Yarra Valley, Australia
,2017, 'A framework for hepatitis C virus treatment as prevention in the prison setting: the SToP-C implementation toolkit', presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)31387-9
,2017, 'Establishment of InC3 viral sequence repository and its applications', presented at 12th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Barossa Valley, Australia
,2016, 'Bayesian evolutionary analysis of hepatitis C epidemic in Australia and North America in 20th century', presented at Australasian Viral Hepatitis Conference, GoldCoast, Australia
,2016, 'Bayesian evolutionary analysis of hepatitis C epidemic in Australia and North America in 20th century', presented at International conference in Systems Biology, Barcelona, Spain
,2016, 'Broadly neutralizing antibodies against hepatitis C envelope; using a network approach to understand co-evolution of critical residues', presented at International conference in Systems Biology, Barcelona, Spain
,2016, 'Examining past and future hepatitis C virus epidemic trends in the era of directly acting antivirals', presented at Australian Society of Microbiology annual scientific meeting, Perth, Australia
,2016, 'Molecular epidemiology of full length hepatitis C virus genomes among injecting drug users with recent infection: The InC3 study', presented at 5th International Symposium on Hepatitis Care in Substance Users, Oslo, Norway
,2016, 'Trends of Hepatitis C virus infections in North America and Australia in 20th century; back projections from molecular epidemiology', presented at 5th International Symposium on Hepatitis Care in Substance Users, Oslo, Norway
,2015, 'A network approach for the identification of co-evolving mutations in Hepatitis C Virus (HCV) in the context of immune escape against neutralizing antibody responses', presented at COMBINE Student Symposium, Sydney, Australia
,2015, 'Characterizing neutralizing antibody responses targeting founder virus in early primary HCV infection with varying disease outcome', presented at International Symposium on Hepatitis C virus and related viruses, Strasbourg, France
,2015, 'Global molecular epidemiology of acute hepatitis infection via phylogenetic analysis of full length genomes across nine international cohorts', presented at 11th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Hunter Valley, Australia
,2015, 'Identification of co-evolving mutations of the Hepatitis C virus in the context of immune escape against neutralizing antibody responses using a bioinformatics workflow', presented at 8th Australasian virology society meeting, Hunter Valley, Australia
,2015, 'Natural prevalence of HCV resistance associated variants in treatment naïve patients across six genotypes', presented at 11th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Hunter Valley, Australia
,2015, 'Understanding the timing, breadth and potency of neutralising antibody responses against transmitted/founders', presented at 11th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Hunter Valley, Australia
,